LWA
GMAB icon

Lenox Wealth Advisors’s Genmab GMAB Stock Holding History

Lenox Wealth Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-82
Closed -$3K – 739
2021
Q1 		$3K Sell
82
-82
-50% -$3.08K ﹤0.01% 570
2020
Q4 		$7K Buy
+164
New +$6.13K ﹤0.01% 470

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Lenox Wealth Advisors's GMAB Position: Q2 2021 in Review

Lenox Wealth Advisors sold out of Genmab (GMAB) in Q2 2021, closing a stake of 82 shares — an estimated $3K sold.

Lenox Wealth Advisors first reported a position in GMAB in Q4 2020 and held it in 2 quarters. The position peaked at $7K in Q4 2020. 212 funds tracked by Wall St. Rank hold GMAB as of Q2 2021.

  • Lenox Wealth Advisors reported no remaining Genmab position as of Q2 2021 after selling out during the quarter.
  • Lenox Wealth Advisors sold 82 Genmab shares in Q2 2021, an estimated $3K.
  • Lenox Wealth Advisors first reported a position in Genmab in Q4 2020 and held it in 2 quarters.
  • Lenox Wealth Advisors's Genmab position peaked at $7K in Q4 2020.
  • 212 funds tracked by Wall St. Rank held Genmab as of Q2 2021.

Based on Lenox Wealth Advisors's 13F filing for Q2 2021, filed 8 Jul 2021.